Table II. Allergens that were most frequently detectable by chip technology in the patient group with mastocytosis and in individuals of the control cohort.
Allergen | Mastocytosis (n = 42) | Nonadvanced mastocytosis (n = 34) | Advanced mastocytosis (n = 8) | Controls (n = 42) |
---|---|---|---|---|
Ves v 5 | 16.7 | 17.6 | 12.5 | 16.7 |
Bet v 1 | 11.9 | 14.7 | 0 | 9.5 |
Aln g 1 | 9.5 | 11.8 | 0 | 7.1 |
Cor a 1.0401 | 7.1 | 8.8 | 0 | 7.1 |
Phl p 1 | 9.5 | 11.8 | 0 | 14.3 |
Phl p 5 | 7.1 | 8.8 | 0 | 14.3 |
Ole e 1 | 7.1 | 8.8 | 0 | 7.1 |
Values represent % of patients. Sera obtained from 42 patients with mastocytosis and 42 controls without mastocytosis were analyzed for specific IgE by the chip. Results for the chip-positive cases are shown as a percentage of all patients in each group. Allergen designation: Aln g 1, pathogenesis-related protein (PR-10) from alder; Bet v 1, PR-10, pollen from birch; Cor a 1.0401, PR-10 from hazelnut; Ole e 1, common olive group 1 (olive); Phl p 1, beta-expansin, pollen from timothy grass; Phl p 5, pollen from timothy grass; Ves v 5, antigen 5, venom from yellow jacket.